A scalable solution for multi-symptom disease prediction and lifestyle recommendations using machine learning
Akbar Hussain, Saif Al‐jumaili, Faiza Tahir, Sehrish Munawar Cheema, Eshmal Malik, Amna Anwar, Frederico Branco, Ivan Miguel Pires
University of Management and Technology University of Lisbon AquaValor Centro de Valorização e Transferência de Tecnologia da Água University of Trás-os-Montes and Alto Douro
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
Accurate prediction of diseases from multiple co-occurring symptoms remains an important challenge in intelligent healthcare systems. Machine-learning models can support early symptom-based risk screening; however, their clinical use is limited by dataset quality, lack of external validation, interpretability concerns, and the risk of overstated diagnostic claims. This study presents a mobile decision-support prototype for multi-symptom disease prediction and rule-based lifestyle recommendation. The experiments were conducted using the publicly available Kaggle Medicine Recommendation System Dataset, which contains 4,920 symptom-based records spanning 41 disease classes, along with supporting files for disease descriptions, precautions, medications, dietary suggestions, and workout recommendations. Seven supervised machine-learning models were evaluated, including Decision Tree, Random Forest, Naive Bayes, Logistic Regression, XGBoost, Support Vector Machine, and K-Nearest Neighbors. The best-performing models achieved high classification accuracy under the adopted evaluation protocol. To avoid overinterpretation, these results are reported as benchmark performance on a secondary public dataset rather than evidence of clinical diagnostic validity. The Android-Flask prototype links the predicted disease class to a lookup-based recommendation layer that retrieves disease-associated information from supporting datasets. The system should therefore be interpreted as a decision-support and educational prototype, not as a clinically validated diagnostic or prescribing tool. Future work should include external validation in independent clinical cohorts, clinician assessment of recommendations, robustness testing under missing or noisy symptom data, and broader evaluation across real-world healthcare settings.
逐年被引趋势
关键指标
同类平均 = 1
同领域 · 同年份 · 同类型
Google Scholar 与 OpenAlex 的被引统计范围不同,数值存在差异属正常。
AI 辅助阅读
依据:摘要
可就本文提问;依据不足时会说明。
学术脉络
学科主题
生物医学Artificial Intelligence in Healthcare
Innovation in Digital Healthcare Systems · Internet of Things and AI